+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Host leukocytes and their products in chronic kidney allograft rejection in rats



Host leukocytes and their products in chronic kidney allograft rejection in rats



Transplant International 7 Suppl 1: S325-S327



Bilaterally nephrectomized Lewis recipients of Fisher 344 (F344) kidney allografts, treated with CyA (1.5 mg/kg/day x 10), develop progressive changes of chronic rejection. Treated F344-to-F344 acted as isograft controls. Proteinuria was determined sequentially. Grafts were harvested 8, 12 and 16 weeks after transplantation (n = 9/group/time period). Infiltrating host cells and their products were assessed in chronically rejecting grafts by histology and immunostaining using mAbs for monocyte/macrophages, T-cells, ICAM-1, LFA-1 and cytokines. For in vitro binding studies, snap-frozen sections of transplanted kidneys were incubated with monocytes/macrophages and lymphocytes isolated from peripheral blood (PBL) of naive animals. For in vivo migration studies, naive cell populations were labeled with Bis-Benzamide and transferred i.v. to grafted animals at weeks 8, 12 and 16 (n = 3/group); grafts were harvested 24 h later and cell localization assessed under immunofluorescence. Increasing numbers of ED1 + monocytes/macrophages in allografted kidneys peaked at 16 weeks, localizing preferentially in glomeruli, where IL-1, IL-6 and TNF-alpha expression had also become intense and correlated with progressive glomerulosclerosis. Binding studies corroborated these results. In vitro, a few monocytes/macrophages bound to glomeruli and vessels at 8 weeks; by 12 weeks, binding to glomeruli was high (72% of cells). In vivo, large numbers of transferred labelled monocytes/macrophages were found in kidney allografts at 12 weeks (23%, isografts; < 7%, P < 0.01). In contrast T cells (primarily CD4+) were a consistent feature in allografts elevated as compared to isografts and correlating with in vitro and in vivo binding patterns; associated cytokines included IL-2, IFN- and TNF-alpha. Functional data followed these results: urine protein excretion by allograft recipients increased from baseline at 8 weeks (12 mg/day) to > 50 mg/day at 16 weeks at which point animals were beginning to die of renal failure; proteinuria in isografted rats did not increase during this time period. These results suggest that monocyte/macrophage and CD4+ T cells and their products are important in chronic kidney allograft rejection, contributing to the progressive sclerosis and fibrosis.

(PDF emailed within 0-6 h: $19.90)

Accession: 046274846

Download citation: RISBibTeXText

PMID: 11271242

DOI: 10.1111/j.1432-2277.1994.tb01382.x


Related references

Tacrolimus reduces the pace of chronic kidney allograft rejection in rats. Nephrology Dialysis Transplantation 11(6): A299, 1996

IL-2 dependent mechanisms are involved in chronic kidney allograft rejection in rats. Journal of the American Society of Nephrology 9(PROGRAM AND ABSTR ISSUE): 657A, Sept, 1997

Influence of renal mass on chronic kidney allograft rejection in rats. Transplantation Proceedings 27(1): 549-549, 1995

Involvement of interleukin-2 and growth factors in chronic kidney allograft rejection in rats. Transplantation Proceedings 33(3): 2160-2162, 2001

Antibody-mediated vascular rejection of kidney allograft: characterization of different kidney allograft rejection phenotypes via histology, C4d deposition and donor-specific antibodies. Clinical and Experimental Immunology 178 Suppl 1: 59-60, 2015

T cells mediating early acute kidney allograft rejection in the rat are different from those responsible for chronic rejection. Transplantation Proceedings 25(1 Pt 2): 863-864, 1993

Some aspects of nucleoside and nucleotide metabolism in the peripheral leukocytes during kidney allograft rejection. Revue Roumaine de Physiologie 10(2): 149-161, 1973

Effect of delayed graft function, acute rejection and chronic allograft dysfunction on kidney allograft telomere length in patients after transplantation: a prospective cohort study. Bmc Nephrology 16(): 23-23, 2016

Host mechanisms of acute and chronic allograft rejection. Lieberman, R [Author], Mukherjee, A [Author] Principles of drug development in transplantation and autoimmunity 21-29, 1996

Chronic kidney isograft and allograft rejection. Journal of Huazhong University of Science and Technology. Medical Sciences 22(3): 253-254, 2003

Changes of chronic kidney allograft rejection are reversible after retransplantation. Transplantation Proceedings 25(1 Pt 2): 906-907, 1993

Inhibition of chronic kidney allograft rejection by cyclosporine. Transplantation Proceedings 21(1 Pt 2): 1660-1662, 1989

Rat cytomegalovirus infection and chronic kidney allograft rejection. Transplant International 9 Suppl 1: S3-S4, 1996

The cellular basis of cardiac allograft rejection: VIII. Mechanisms underlying delayed allograft rejection in PVG C6-deficient rats. Transplantation 65(9): 1152-1158, 1998